Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy S Frieling

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|June 12, 2019
Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal MalignancyJeremy S Frieling, Conor C Lynch
Cancer Research|December 2, 2024
Tales of Cancer-Induced Bone Disease from the Senescent Osteocyte CryptJeremy S Frieling, Conor C Lynch
Cancer Control : Journal of the Moffitt Cancer Center|December 16, 2014
Current and emerging therapies for bone metastatic castration-resistant prostate cancerJeremy S Frieling, David Basanta, Conor C Lynch
Journal of Bone Oncology|July 10, 2024
Emerging roles for stromal cells in bone metastasisKarl J Nyman, Jeremy S Frieling, Conor C Lynch
Neoplasia (New York, N.Y.)|September 8, 2020
Prostate cancer-derived MMP-3 controls intrinsic cell growth and extrinsic angiogenesisJeremy S Frieling, Tao Li, Marilena Tauro, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 26, 2019
CAR-T Engineering: Optimizing Signal Transduction and Effector MechanismsEmiliano Roselli, Jeremy S Frieling, Konrad Thorner, et al.
Oncogene|August 15, 2019
Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesisLeah M Cook, Jeremy S Frieling, Niveditha Nerlakanti, et al.
Nature Communications|February 2, 2021
Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancerJeremy J McGuire, Jeremy S Frieling, Chen Hao Lo, et al.
Cancer Research|October 17, 2025
PRDM16 Regulates Prostate Cancer Cell Dormancy and Prevents Bone Metastatic OutgrowthMostafa M Nasr, Bishoy Wadie, Tao Li, et al.
Cancers|February 11, 2021
Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate CancerArturo Araujo, Leah M Cook, Jeremy S Frieling, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|June 12, 2019
Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal MalignancyJeremy S Frieling, Conor C Lynch
Cancer Research|December 2, 2024
Tales of Cancer-Induced Bone Disease from the Senescent Osteocyte CryptJeremy S Frieling, Conor C Lynch
Cancer Control : Journal of the Moffitt Cancer Center|December 16, 2014
Current and emerging therapies for bone metastatic castration-resistant prostate cancerJeremy S Frieling, David Basanta, Conor C Lynch
Journal of Bone Oncology|July 10, 2024
Emerging roles for stromal cells in bone metastasisKarl J Nyman, Jeremy S Frieling, Conor C Lynch
Neoplasia (New York, N.Y.)|September 8, 2020
Prostate cancer-derived MMP-3 controls intrinsic cell growth and extrinsic angiogenesisJeremy S Frieling, Tao Li, Marilena Tauro, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 26, 2019
CAR-T Engineering: Optimizing Signal Transduction and Effector MechanismsEmiliano Roselli, Jeremy S Frieling, Konrad Thorner, et al.
Oncogene|August 15, 2019
Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesisLeah M Cook, Jeremy S Frieling, Niveditha Nerlakanti, et al.
Nature Communications|February 2, 2021
Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancerJeremy J McGuire, Jeremy S Frieling, Chen Hao Lo, et al.
Cancer Research|October 17, 2025
PRDM16 Regulates Prostate Cancer Cell Dormancy and Prevents Bone Metastatic OutgrowthMostafa M Nasr, Bishoy Wadie, Tao Li, et al.
Cancers|February 11, 2021
Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate CancerArturo Araujo, Leah M Cook, Jeremy S Frieling, et al.
Pageof 2